Salernitan Medical School or Langobardic Medical School?


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
12 05 2021
Historique:
received: 19 12 2019
accepted: 19 12 2019
entrez: 14 5 2021
pubmed: 15 5 2021
medline: 29 6 2021
Statut: epublish

Résumé

Already famous since the high Middle Ages, the Salernitan Medical School reached its whole scientific role between the 11th and 12th century, declining later due to the rising of modern universities. Information on the earliest period of the School is very poor but, starting from the 10th century, we know that Salernitan physicians were widely recognized as researchers and healers. This paper is focused on the heavy role recognized to the Langobards (first) and Normans (later) on development of the Salernitan Medical School. A special role must be recognized to Alfanus I, Gariopontus and Trotula de Ruggiero: they left memories on their enterprises and many manuscripts of great relevance for the development of Middle Ages and Renaissance Medicine. Their multicultural experience dragged the Salernitan School to become the greatest expression of medical science of its age. This role was expressed in the "Regimen Sanitatis Salernitanum" or "Flos Medicinae Salerni", a book that resumes the highest knowledges on general hygiene, dietetics, physiotherapy, comparative anatomy and surgery. The book had a tremendous success, having more than 300 editions in many languages up to 1846. It was an essential reference for western medical literature up to Renaissance. Furthermore, Langobards took care of health laws, mainly in the Rotari edict, which included laws on medical practice and on the physicians' role. (www.actabiomedica.it).

Identifiants

pubmed: 33988182
doi: 10.23750/abm.v92i2.9109
pmc: PMC8182603
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2021015

Références

Sudhoffs Arch. 2002;86(1):1-26
pubmed: 12168232
Proc R Soc Med. 1940 Jun;33(8):471-5
pubmed: 19992237

Auteurs

Ugo Longobardi (U)

Hospital of Arezzo. pancreas1@inwind.it.

Michele Mitaritonno (M)

Hospital of Cosenza. mitarim@hotmail.com.

Gianfranco Cervellin (G)

University Hospital of Parma, Italy. gianfranco.cervellin@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH